4,380 Shares in iShares NASDAQ Biotechnology Index (IBB) Acquired by Hikari Tsushin Inc.

Hikari Tsushin Inc. bought a new stake in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) in the 1st quarter, HoldingsChannel reports. The institutional investor bought 4,380 shares of the financial services provider’s stock, valued at approximately $468,000.

Several other hedge funds have also recently made changes to their positions in the company. TLP Group LLC increased its holdings in iShares NASDAQ Biotechnology Index by 590.2% during the first quarter. TLP Group LLC now owns 33,128 shares of the financial services provider’s stock worth $3,536,000 after buying an additional 28,328 shares during the last quarter. Glacier Peak Capital LLC purchased a new stake in iShares NASDAQ Biotechnology Index during the first quarter worth about $220,000. Quattro Financial Advisors LLC increased its holdings in iShares NASDAQ Biotechnology Index by 200.0% during the first quarter. Quattro Financial Advisors LLC now owns 11,089 shares of the financial services provider’s stock worth $1,159,000 after buying an additional 7,393 shares during the last quarter. STA Wealth Management LLC increased its holdings in iShares NASDAQ Biotechnology Index by 6.3% during the first quarter. STA Wealth Management LLC now owns 106,064 shares of the financial services provider’s stock worth $11,321,000 after buying an additional 6,315 shares during the last quarter. Finally, Amussen Hunsaker Associates LLC increased its holdings in iShares NASDAQ Biotechnology Index by 31.9% during the first quarter. Amussen Hunsaker Associates LLC now owns 13,869 shares of the financial services provider’s stock worth $1,480,000 after buying an additional 3,355 shares during the last quarter. Institutional investors own 60.10% of the company’s stock.

iShares NASDAQ Biotechnology Index traded up $0.32, reaching $110.81, during trading hours on Thursday, according to Marketbeat.com. 18,397 shares of the company were exchanged, compared to its average volume of 2,821,399. iShares NASDAQ Biotechnology Index has a 1 year low of $96.84 and a 1 year high of $119.30.

About iShares NASDAQ Biotechnology Index

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply